Form 4: Harvard Bioscience CEO James W. Green Acquires Shares and RSUs
SEC Form 4
James W. Green, CEO of Harvard Bioscience, reports acquisition of common stock and restricted stock units (RSUs).
Summary
- On March 5, 2024, James W. Green, the CEO of Harvard Bioscience, acquired 214,797 shares of common stock at $0.00 and 214,797 RSUs.
- Following these transactions, Green directly owns 2,866,294 shares of common stock and 3,081,091 RSUs.
- The RSUs vest in installments, with some vesting based on performance criteria.
Sentiment
Score: 6
Explanation: The sentiment is neutral. It's a standard SEC filing detailing stock and RSU acquisitions by the CEO. While insider buying can be seen as positive, it's a routine occurrence and doesn't necessarily indicate a strong positive or negative outlook.
Positives
- The acquisition of shares and RSUs by the CEO could be interpreted as a sign of confidence in the company's future prospects.
Future Outlook
The actual number of RSUs awarded may vary between 0% and 150% of the target, depending on the Company's performance through December 31, 2026.
Industry Context
This filing is a routine disclosure of insider transactions, which are common in publicly traded companies. It provides transparency into the holdings and transactions of company executives.
Stakeholder Impact
- The transaction could have a minor positive impact on shareholder sentiment due to the CEO's increased stake in the company.
Key Dates
| Date | Description |
|---|---|
| 03/05/2024 | Date of transaction: Acquisition of common stock and RSUs |
| 03/07/2024 | Date of signature for the Form 4 filing |
| 03/19/2025 | First vesting date for a portion of the acquired RSUs |
| 12/29/2024 | Vesting date for 235,427 RSUs in two equal installments |
| 12/29/2024 | Vesting date for 52,346 RSUs |
| 03/19/2026 | Second vesting date for a portion of the acquired RSUs |
| 12/31/2026 | End of performance period for performance-based RSUs |
| 03/19/2027 | Third vesting date for a portion of the acquired RSUs |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.